CRIS Current Research Information System

RAVAIOLI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.099
AS - Asia 17.692
EU - Europa 13.930
AF - Africa 1.291
SA - Sud America 1.107
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 12
Totale 53.168
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.878
SG - Singapore 5.359
CN - Cina 4.818
VN - Vietnam 3.958
IT - Italia 3.353
GB - Regno Unito 2.734
DE - Germania 1.844
SE - Svezia 1.643
HK - Hong Kong 1.428
IN - India 889
BR - Brasile 825
FR - Francia 702
RU - Federazione Russa 688
IE - Irlanda 571
NL - Olanda 525
UA - Ucraina 521
KR - Corea 514
CI - Costa d'Avorio 391
TG - Togo 304
FI - Finlandia 277
ZA - Sudafrica 230
CH - Svizzera 218
SC - Seychelles 197
EE - Estonia 189
JP - Giappone 171
BG - Bulgaria 168
JO - Giordania 129
AR - Argentina 125
CA - Canada 125
AT - Austria 122
ID - Indonesia 97
NG - Nigeria 94
ES - Italia 78
MX - Messico 71
BE - Belgio 70
PL - Polonia 59
EC - Ecuador 58
BD - Bangladesh 55
TR - Turchia 52
IR - Iran 44
AU - Australia 27
RO - Romania 26
HR - Croazia 25
LT - Lituania 25
PH - Filippine 23
PK - Pakistan 22
IQ - Iraq 21
MA - Marocco 20
PE - Perù 19
UZ - Uzbekistan 19
CO - Colombia 18
PY - Paraguay 18
UY - Uruguay 16
CL - Cile 15
GR - Grecia 15
EG - Egitto 13
MK - Macedonia 13
AE - Emirati Arabi Uniti 12
MY - Malesia 12
SA - Arabia Saudita 12
PT - Portogallo 11
LB - Libano 10
TN - Tunisia 10
CZ - Repubblica Ceca 9
VE - Venezuela 9
DK - Danimarca 7
NZ - Nuova Zelanda 7
AL - Albania 6
EU - Europa 6
KE - Kenya 6
AZ - Azerbaigian 5
CR - Costa Rica 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
IL - Israele 5
KZ - Kazakistan 5
LK - Sri Lanka 5
NO - Norvegia 5
RS - Serbia 5
GA - Gabon 4
HU - Ungheria 4
LU - Lussemburgo 4
SN - Senegal 4
A2 - ???statistics.table.value.countryCode.A2??? 3
KG - Kirghizistan 3
NP - Nepal 3
PA - Panama 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
CG - Congo 2
GN - Guinea 2
HN - Honduras 2
KH - Cambogia 2
LV - Lettonia 2
MD - Moldavia 2
ME - Montenegro 2
MM - Myanmar 2
Totale 53.126
Salva come PNG Salva come JPEG
Città #
Singapore 3.542
Ashburn 2.285
Southend 2.266
Fairfield 1.896
Chandler 1.689
Hong Kong 1.423
Hefei 1.134
Dong Ket 912
Woodbridge 905
Ho Chi Minh City 887
Santa Clara 878
Wilmington 794
Houston 779
Seattle 778
Hanoi 700
Princeton 693
Bologna 646
Cambridge 643
Beijing 592
Dublin 567
Boardman 540
Seoul 509
Ann Arbor 453
Dallas 408
Abidjan 390
Los Angeles 317
Lomé 304
Jacksonville 292
Milan 261
Nanjing 232
Westminster 230
Berlin 212
Padova 203
Helsinki 196
Munich 195
New York 195
Bern 175
Buffalo 167
Sofia 165
Tokyo 164
Rome 148
Redondo Beach 147
Jinan 142
Turin 140
Florence 135
Amman 129
Saint Petersburg 123
Shenyang 117
San Diego 112
Frankfurt am Main 104
Guangzhou 103
São Paulo 102
Bengaluru 101
Redmond 98
Da Nang 90
Des Moines 88
Changsha 87
Shanghai 86
London 84
Medford 84
Dearborn 83
Falkenstein 77
Abeokuta 76
Bremen 75
Haiphong 75
Nanchang 71
Chicago 67
Hebei 67
Nuremberg 65
Zhengzhou 65
Phoenix 64
Vienna 64
Brussels 62
Hyderabad 60
Jiaxing 59
Düsseldorf 57
Jakarta 57
Biên Hòa 56
Hải Dương 56
Mülheim 56
Tianjin 55
Amsterdam 54
Toronto 52
Quận Bình Thạnh 49
Turku 47
Olalla 46
Hangzhou 45
Ha Long 44
Redwood City 44
Brooklyn 43
Naples 41
Bühl 38
Haikou 38
Ninh Bình 38
San Francisco 38
Falls Church 37
Norwalk 37
Rio de Janeiro 37
Paris 36
Tongling 36
Totale 34.004
Salva come PNG Salva come JPEG
Nome #
Long Term Outcomes of Kidney Transplant: Characteristics of Recipients with 20 or More Years of Graft Survival 861
The histological assessment of liver fibrosis in grafts from extended criteria donors predicts the outcome after liver transplantation: A retrospective study 612
Utilizzo della perfusione ex-vivo in pazienti con epatocarcinoma candidati al trapianto di fegato per ridurre l’incidenza di recidiva del tumore 540
Hepatobiliary Scintigraphy in the Preoperative Evaluation of Potential Living Liver Donors 462
Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries 443
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic 374
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score 338
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study 283
TRAPIANTO DI FEGATO CON TROMBOSI PORTALE COMPLETA: ESPERIENZA DI 11 CASI TRATTATI MEDIANTE ANASTOMOSI TRA LA VENA PORTA DEL GRAFT E LA VARICE GASTRICA DEL RICEVENTE 280
A comprehensive analysis on expected years of life lost due to pancreatic cancer 273
Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study 268
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 260
Applicazioni innovative di vescicole extracellulari derivanti da cellule staminali mesenchimali a scopo di ricondizionamento di reni per il trapianto 248
Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases: 5-year analysis. 239
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study 237
A new liver transplant priority for patients with hepatocellular carcinoma. 232
A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system. 232
Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis. 229
Adding Liver Stiffness Measurement to the Routine Evaluation of Hepatocellular Carcinoma Resectability Can Optimize Clinical Outcome 227
Impact of Bacillus Calmette-Guerin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection 224
[Angiogenic factors and their relation to stage, lymph-node micrometastases and prognosis in patients operated on for gastric cancer] 223
Comprehensive surgical intestinal rescue and transplantation program in adult patients: Bologna experience. 218
Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma. 215
Surgical therapy for hepatolithiasis: a Western experience. 215
Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic 212
In hepatocellular carcinoma miR-221 modulates sorafenib resistance through inhibition of caspase-3–mediated apoptosis 212
Causes of early acute graft failure after liver transplantation: analysis of a 17-year single-centre experience. 211
A new prognostic model to predict drop-out from the waiting list in cirrhotic candidates for liver transplantation wirh MELD score <18. 203
A partnership model between high- And low-volume hospitals to improve results in hepatobiliary pancreatic surgery 198
Combined kidney-liver, heart-liver, and kidney-pancreas transplantations from a single deceased donor. 197
The Effect of a Liver Transplant Program on the Outcomes of Resectable Hepatocellular Carcinoma: A Nationwide Multicenter Analysis 196
Machine Learning Pipeline for the Automated Prediction of MicrovascularInvasion in HepatocellularCarcinomas 196
The physical, sedimentary and ecological structure and variability of shelf areas in the Mediterranean Sea 196
Associated benign liver tumors in idiopathic granulomatous hepatitis: a case report 195
Can antiplatelet prophylaxis reduce the incidence of hepatic artery thrombosis after liver transplantation? 195
Combined liver–dual kidney transplant: Role in expanded donors 193
MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma 191
Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center 191
Gut microbiome dynamics and Enterobacterales infection in liver transplant recipients: A prospective observational study 190
Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. 190
Assessment of Radiofrequency Ablation Efficacy for Hepatocellular Carcinoma by Histology and Pre-transplant Radiology 189
Coping strategies in intestinal transplantation 188
LncRNAs as novel players in hepatocellular carcinoma recurrence 188
Italian experience in adult clinical intestinal and multivisceral transplantation: 6 years later. 187
Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study 187
Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria. 186
Reliability of imaging techniques in assessing portal venous thrombosis in patients with hepatocellular carcinoma candidates for liver transplantation 184
The role of lymphadenectomy for liver tumors. Further considerations on the appropriateness of treatment strategy 183
Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era. 183
Histological recurrent hepatitis C after liver transplantation: Outcome and role of retransplantation. 183
Affidabilità della combinazione di angioecografia perfusionale ed altre tecniche di imaging nella valutazione della trombosi portale in pazienti con epatocarcinoma (HCC) candidati al trapianto di fegato 183
Conventional split liver transplantation for two adult recipients: a recent experience in a single European center 181
Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study 181
Delaying surgery for patients with a previous SARS-CoV-2 infection 180
MiR-30e-3p influences tumor phenotype through MDM2/TP53 axis and predicts sorafenib resistance in hepatocellular carcinoma 178
Efficacy of MELD score in predicting survival after liver retransplantation. 176
Assessment of donor steatosis in liver transplantation: is it possible without liver biopsy? 176
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. 176
Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular carcinoma. 174
Using Elderly Donors in Liver Transplantation. 173
Aumento della xantina ossidoreduttasi sierica dopo trapianto di fegato 173
Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma. 173
Hypothermic Oxygenated New Machine Perfusion System in Liver and Kidney Transplantation of Extended Criteria Donors:First Italian Clinical Trial 171
Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers. 169
Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients. 169
Daclizumab and Alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: A comparison of two different regimens on 29 recipients during the early post-operative period. 169
Pre-transplant psoas muscle density as a ready-to-use and low-cost predictor of patient survival after liver transplant 168
Strategies to Restore Adenosine Triphosphate (ATP) Level After More than 20 Hours of Cold Ischemia Time in Human Marginal Kidney Grafts. 168
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 168
Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period. 167
Automatically extracted machine learning features from preoperative CT to early predict microvascular invasion in HCC: the role of the Zone of Transition (ZOT) 167
Heterotopic auxiliary segment 2–3 liver transplantation with delayed total hepatectomy: New strategies for nonresectable colorectal liver metastases 166
Heterotopic segmental liver transplantation on splenic vessels after splenectomy with delayed native hepatectomy after graft regeneration: A new technique to enhance liver transplantation 166
null 164
Prediction of Three-Year Outcome of Renal Transplantation from Optimal Donors versus Expanded Criteria Donors. 164
Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients 164
Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population. 163
Epigenetic and epitranscriptomic changes in colorectal cancer: diagnostic, prognostic, and treatment implications 163
Thorough assessment of portal venous thrombosis in patients with HCC allows adequate selection of candidates for liver transplantation 163
Impact of preoperative infection on outcome after liver transplantation 162
Age and equity in liver transplantation: An organ allocation model. 160
Molecular and proteomic insight into Notch1 characterization in hepatocellular carcinoma 160
Incidence, clinical significance, and outcome of vascular alterations in intestinal biopsies after isolated small bowel transplantation: a single-center experience. 159
Induction therapy with Alemtuzumab (Campath) in combined liver-kidney transplantation: University of Bologna experience. 158
Incidence and management of abdominal closure-related complications in adult intestinal transplantation. 158
Ruolo della linfadenectomia in corso di epatectomia per metastasi colorettali. 157
Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience. 157
Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: a pilot study. 157
Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation. 156
Can the dropout risk of candidates with hepatocellular carcinoma predict survival after liver transplantation? 156
Rejection episodes and 3-year graft survival under sirolimus and tacrolimus treatment after adult intestinal transplantation. 155
Assessment of perioperative transfusion requirement for cirrhotic patients undergoing elective hepatectomy 154
Safety and prognostic role of regional lymphadenectomy for primary and metastatic liver tumors. 153
Detection of recipient's cells in liver graft using antibodies to mismatched HLA class I antigens 153
Fifteen-year analysis of deceased kidney donation: A single transplant center experience in a region of northern Italy 153
MiR-199-3p replacement affects E-cadherin expression through Notch1 targeting in hepatocellular carcinoma 153
Facing the enigma of the vascular network in hepatocellular carcinomas in cirrhotic and non-cirrhotic livers. 153
Histological Evidence of Diabetic Kidney Disease Precede Clinical Diagnosis 152
The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantation 152
Complex Liver Transplantation Using Venovenous Bypass With an Atypical Placement of the Portal Vein Cannula 152
Totale 20.980
Salva come PNG Salva come JPEG
Categoria #
all - tutte 157.407
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 157.407
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.827 0 0 0 0 0 206 109 225 425 280 164 1.418
2021/20226.179 479 216 332 464 535 260 137 570 236 384 1.495 1.071
2022/20237.904 710 1.081 379 931 640 664 301 503 1.347 239 660 449
2023/20242.643 225 438 173 258 178 440 118 164 87 204 176 182
2024/202510.987 529 1.364 972 859 1.430 599 709 355 272 917 796 2.185
2025/202613.794 3.278 3.093 2.305 1.930 2.572 616 0 0 0 0 0 0
Totale 54.258